Post-chemotherapy residual mass in stage IIC seminomatous testicular tumor.
نویسندگان
چکیده
منابع مشابه
Post-chemotherapy residual mass in non-seminomatous testicular cancer. The role of retroperitoneal lymph node dissection.
PURPOSE To determine the role of RPLND for residual masses following chemotherapy in patients with non-seminomatous germ cell tumors (NSGCT) stage T1N2 and T1N3 (IIB and IIC). MATERIALS AND METHODS We have preformed retrospective analysis of 11 patients who underwent RPLND for residual masses following chemotherapy in an oncologic reference center between January 1997 and December 2002. All p...
متن کاملRetroperitoneal lymphadenectomy by videolaparoscopic transperitoneal approach in patients with non-seminomatous testicular tumor.
OBJECTIVE The present study aims to report the preliminary experience with videolaparoscopic retroperitoneal lymphadenectomy in the treatment of patients with non-seminomatous testicular tumor. MATERIALS AND METHODS Seven surgeries were performed in order to access retroperitoneal lymph nodes in patients with non-seminomatous testicular cancer. We performed the videolaparoscopic retroperitone...
متن کاملFDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment
The value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in detecting viable tumours in patients with metastasised non-seminomatous testicular cancer and residual and new masses post chemotherapy remains to be determined. We describe the case of a 41-year-old patient with metastasised non-seminomatous testicular cancer, with both retroperitoneal and ext...
متن کاملActual developments in European regula- tory and health technology assessment of new cancer drugs: what does this mean for oncology in Europe? introduction
non-seminomatous germ cell tumors who undergo post-chemotherapy RPLND for small tumors. J Clin Oncol 2011; 29 (abstr 224). 19. Ehrlich Y, Brames MJ, Beck S et al. Long-term followup of cisplatin combination chemotherapy in patients with disseminated non-seminomatous germ cell tumors: is a post-chemotherapy RPLND needed after complete remission? J Clin Oncol 2010; 28: 531–536. 20. Kollmannsberge...
متن کاملHistopathological assessment of residual retroperitoneal mass removed in patients after chemotherapy for non-seminomatous germ cell tumours of the testis.
Between 1990 and 1999, 182 men were treated for non-seminomatous germ cell testicular tumours. In 24 of them after chemotherapy a residual retroperitoneal mass was removed. In 14 of them additional immunohistochemical (IHC) examinations using antibodies against cytokeratins, vimentin, PLAP, CD30, AFP, βhCG, p53, and MIB-1 were performed. We compared the results of those additional studies with ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- JPMA. The Journal of the Pakistan Medical Association
دوره 52 12 شماره
صفحات -
تاریخ انتشار 2002